Search Results 181-190 of 15951 for pharmacogenetics
The purpose of this study is to identify susceptibility genes for venous thromboembolism (VTE) using conventional and novel genetic-epidemiologic methods in ...
Learn about a healthcare career as a genetic counselor, including what they do, where they work, and the program at Mayo Clinic College of Medicine and ...
The purpose of this study is perform HOUSES index analysis on 500 patients with a first-degree relative diagnosed with pancreatic cancer to see if there is a ...
About this study. The purpose of this study is to establish at least 200 patient-derived cancer xenografts (PDXs), and to utilize these PDXs in preclinical ...
National Human Genome Research Institute: Polygenic risk scores. CanRisk breast and ovarian cancer risk calculator. Publications. The eMERGE Network recommends ...
Learn how genetic testing can help customize your cancer treatment plan. Precision medicine is improving breast cancer diagnosis, treatment and prevention.
Global collaboration is needed to make sure that a new type of genetic test, the polygenic risk score, performs equitably among people from diverse groups.
The eMERGE Genome Informed Risk Assessment study at Mayo Clinic uses polygenic risk scores to estimate participants' overall risk getting certain diseases.
In January 2017, the Cytogenetics Laboratory and Molecular Genetics Laboratory combined to form one laboratory now known as the Genomics Laboratory. To reflect ...
ATLANTA – A group of investigators from Mayo Clinic and multiple academic research centers in Italy have identified a genetic model for predicting outcomes ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.